FibroBiologics, Inc. (FBLG)
0.95
-0.07
(-6.86%)
USD |
NASDAQ |
Oct 23, 16:00
0.9643
+0.01
(+1.51%)
After-Hours: 20:00
FibroBiologics Market Cap : 5.777M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.777M |
| October 22, 2026 | 6.202M |
| October 21, 2026 | 6.038M |
| October 20, 2026 | 5.594M |
| October 19, 2026 | 5.741M |
| October 16, 2026 | 5.904M |
| October 15, 2026 | 6.081M |
| October 14, 2026 | 5.777M |
| October 13, 2026 | 5.837M |
| October 12, 2026 | 6.081M |
| October 09, 2026 | 6.871M |
| October 08, 2026 | 6.750M |
| October 07, 2026 | 6.932M |
| October 06, 2026 | 6.871M |
| October 05, 2026 | 7.175M |
| October 02, 2026 | 7.540M |
| October 01, 2026 | 7.327M |
| September 30, 2026 | 7.905M |
| September 29, 2026 | 7.966M |
| September 28, 2026 | 8.270M |
| September 25, 2026 | 8.452M |
| September 24, 2026 | 8.270M |
| September 23, 2026 | 8.087M |
| September 22, 2026 | 8.148M |
| September 21, 2026 | 8.270M |
| Date | Value |
|---|---|
| September 18, 2026 | 8.695M |
| September 17, 2026 | 9.030M |
| September 16, 2026 | 8.695M |
| September 15, 2026 | 8.756M |
| September 14, 2026 | 9.425M |
| September 11, 2026 | 9.790M |
| September 10, 2026 | 10.52M |
| September 09, 2026 | 10.70M |
| September 08, 2026 | 10.40M |
| September 04, 2026 | 11.01M |
| September 03, 2026 | 10.70M |
| September 02, 2026 | 11.86M |
| September 01, 2026 | 12.83M |
| August 31, 2026 | 10.46M |
| August 28, 2026 | 8.756M |
| August 27, 2026 | 9.060M |
| August 26, 2026 | 8.574M |
| August 25, 2026 | 8.513M |
| August 24, 2026 | 8.209M |
| August 21, 2026 | 8.756M |
| August 20, 2026 | 7.844M |
| August 19, 2026 | 7.236M |
| August 18, 2026 | 6.932M |
| August 17, 2026 | 6.202M |
| August 14, 2026 | 6.445M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| PEG Ratio | -0.0059 |
| Price to Book Value | 1.246 |
| Price | 0.95 |
| Earnings Yield | -593.7% |
| PEGY Ratio | -0.0059 |